Corcept Therapeutics
CORT
CORT
245 hedge funds and large institutions have $2.26B invested in Corcept Therapeutics in 2023 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 81 increasing their positions, 92 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
245
Holders Change
+20
Holders Change %
+8.89%
% of All Funds
3.91%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
39
Increased
81
Reduced
92
Closed
16
Calls
$11.5M
Puts
$6.54M
Net Calls
+$4.99M
Net Calls Change
+$4.39M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
$30.1M |
| 2 |
Cerity Partners
New York
|
$13.9M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
$11.8M |
| 4 |
D.E. Shaw & Co
New York
|
$41.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
$18.6M |
